For the year ending 2025-12-31, OCUL has $808,057K in assets. $153,747K in debts. $737,060K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 737,060 | |||
| Accounts receivable, net | 30,650 | |||
| Inventory | 3,564 | |||
| Prepaid expenses and other current assets | 10,855 | |||
| Total current assets | 782,129 | |||
| Property and equipment, net | 19,676 | |||
| Restricted cash | 1,614 | |||
| Operating lease assets | 4,638 | |||
| Total assets | 808,057 | |||
| Accounts payable | 4,154 | |||
| Accrued expenses and other current liabilities | 43,835 | |||
| Operating lease liabilities | 2,817 | |||
| Total current liabilities | 50,806 | |||
| Operating lease liabilities, net of current portion | 2,815 | |||
| Derivative liability | 13,903 | |||
| Deferred revenue, net of current portion | 14,000 | |||
| Notes payable, net | 71,336 | |||
| Other non-current liabilities | 887 | |||
| Total liabilities | 153,747 | |||
| Common stock, 0.0001 par value 400,000,000 and 400,000,000 shares authorized and 215,927,600 and 157,749,490 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 22 | |||
| Additional paid-in capital | 1,811,311 | |||
| Accumulated deficit | -1,157,023 | |||
| Total stockholders' equity | 654,310 | |||
| Total liabilities and stockholders' equity | 808,057 | |||
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)